Pfizer: PARP-inhibitor Combination Treatments in Prostate Cancer

Projects that will be considered for Pfizer support will focus on:

• Increasing understanding of the rationale for PARPi combinations as potential treatments for prostate cancer
• Increasing understanding of patient selection/identification for potential treatment with PARPi combinations for prostate cancer
• Increasing understanding of ongoing clinical trial design exploring PARPi combinations in prostate cancer

Funding: $250,000

https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-09/GMG_2020-I%26I-G_EmergingMOATreatmentM2SAD.pdf?6SCW3sVD0grV.Ci7FAXWT_7DW1nzbvZe